| AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations JL Tang, HA Hou, CY Chen, CY Liu, WC Chou, MH Tseng, CF Huang, ... Blood, The Journal of the American Society of Hematology 114 (26), 5352-5361, 2009 | 412 | 2009 |
| TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics WC Chou, SC Chou, CY Liu, CY Chen, HA Hou, YY Kuo, MC Lee, BS Ko, ... Blood, The Journal of the American Society of Hematology 118 (14), 3803-3810, 2011 | 390 | 2011 |
| DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications HA Hou, YY Kuo, CY Liu, WC Chou, MC Lee, CY Chen, LI Lin, MH Tseng, ... Blood, The Journal of the American Society of Hematology 119 (2), 559-568, 2012 | 301 | 2012 |
| Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations WC Chou, HH Huang, HA Hou, CY Chen, JL Tang, M Yao, W Tsay, BS Ko, ... Blood, The Journal of the American Society of Hematology 116 (20), 4086-4094, 2010 | 268 | 2010 |
| Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation WC Chou, HA Hou, CY Chen, JL Tang, M Yao, W Tsay, BS Ko, SJ Wu, ... Blood, The Journal of the American Society of Hematology 115 (14), 2749-2754, 2010 | 241 | 2010 |
| The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia WC Chou, WC Lei, BS Ko, HA Hou, CY Chen, JL Tang, M Yao, W Tsay, ... Leukemia 25 (2), 246-253, 2011 | 208 | 2011 |
| WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system HA Hou, TC Huang, LI Lin, CY Liu, CY Chen, WC Chou, JL Tang, ... Blood, The Journal of the American Society of Hematology 115 (25), 5222-5231, 2010 | 205 | 2010 |
| TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution HA Hou, WC Chou, YY Kuo, CY Liu, LI Lin, MH Tseng, YC Chiang, ... Blood cancer journal 5 (7), e331-e331, 2015 | 167 | 2015 |
| The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution SJ Wu, YY Kuo, HA Hou, LY Li, MH Tseng, CF Huang, FY Lee, MC Liu, ... Blood, The Journal of the American Society of Hematology 120 (15), 3106-3111, 2012 | 165 | 2012 |
| Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation R Nagase, D Inoue, A Pastore, T Fujino, HA Hou, N Yamasaki, S Goyama, ... The Journal of experimental medicine 215 (6), 1729, 2018 | 148 | 2018 |
| Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia V Madan, P Shyamsunder, L Han, A Mayakonda, Y Nagata, ... Leukemia 30 (8), 1672-1681, 2016 | 147 | 2016 |
| Genetic alterations and their clinical implications in older patients with acute myeloid leukemia CH Tsai, HA Hou, JL Tang, CY Liu, CC Lin, WC Chou, MH Tseng, ... Leukemia 30 (7), 1485-1492, 2016 | 133 | 2016 |
| TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype DA Sallman, AF McLemore, AL Aldrich, RS Komrokji, KL McGraw, ... Blood, The Journal of the American Society of Hematology 136 (24), 2812-2823, 2020 | 132 | 2020 |
| Genomic landscape and clonal evolution of acute myeloid leukemia with t (8; 21): an international study on 331 patients F Christen, K Hoyer, K Yoshida, HA Hou, N Waldhueter, M Heuser, ... Blood, The Journal of the American Society of Hematology 133 (10), 1140-1151, 2019 | 127 | 2019 |
| IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease … CC Lin, HA Hou, WC Chou, YY Kuo, CY Liu, CY Chen, YJ Lai, MH Tseng, ... American journal of hematology 89 (2), 137-144, 2014 | 113 | 2014 |
| Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia HA Hou, CC Lin, WC Chou, CY Liu, CY Chen, JL Tang, YJ Lai, MH Tseng, ... Leukemia 28 (1), 50-58, 2014 | 109 | 2014 |
| Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome TC Chen, HA Hou, WC Chou, JL Tang, YY Kuo, CY Chen, MH Tseng, ... Blood cancer journal 4 (1), e177-e177, 2014 | 105 | 2014 |
| Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ... The Lancet 401 (10373), 269-280, 2023 | 104 | 2023 |
| Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival TTF Shih, HA Hou, CY Liu, BB Chen, JL Tang, HY Chen, SY Wei, M Yao, ... Blood, The Journal of the American Society of Hematology 113 (14), 3161-3167, 2009 | 104 | 2009 |
| Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia HA Hou, CY Liu, YY Kuo, WC Chou, CH Tsai, CC Lin, LI Lin, MH Tseng, ... Oncotarget 7 (8), 9084, 2016 | 97 | 2016 |
